Anders Pedersen

Chief Operating Officer at GALECTO, INC.

Net worth: 2 922 $ as of 2024-03-30

64 year

Health Technology

Consumer Services

Anders Pedersen active positions

Companies	Position	Start	End
GALECTO, INC.	Chief Operating Officer	2019-12-31	-
Galecto Biotech ApS Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.	Chief Operating Officer	2012-12-31	-

Career history of Anders Pedersen

Former positions of Anders Pedersen

Companies	Position	Start	End
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.	Corporate Officer/Principal	2010-01-31	2013-02-28
Recepticon ApS Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects.	Chief Operating Officer	2006-11-30	2009-10-31
Life Cycle Pharma A/S	Corporate Officer/Principal	2005-02-28	2006-10-31
The University of New Mexico	Corporate Officer/Principal	1988-12-31	1989-12-31
Profound Pharma AS Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million.	Chief Tech/Sci/R&D Officer	2009-09-01	-
	Founder	2009-09-01	-
	Corporate Officer/Principal	1998-12-31	2009-09-01
NOVO NORDISK A/S	Corporate Officer/Principal	-	-
Biotech Biotech BiotechnologyHealth Technology The private company manufactures biotechnical products. The company is based in Cambridge, MA.	Corporate Officer/Principal	-	-

Training of Anders Pedersen

Technical University of Denmark

Undergraduate Degree

Statistics

International

Denmark	7
United States	4
	2

Operational

Corporate Officer/Principal	6
Chief Operating Officer	3
Chief Tech/Sci/R&D Officer	1

Sectoral

Health Technology	8
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	2
NOVO NORDISK A/S	Health Technology
GALECTO, INC.	Health Technology

Private companies	6
Profound Pharma AS Profound Pharma AS Pharmaceuticals: MajorHealth Technology Profound Pharma AS provides pharmaceutical products. The Danish company was founded by Jan Møller Mikkelsen, Anders H. Pedersen, Hans Thalsgård Schambye. Profound Pharma was acquired by Maxygen, Inc. on August 10, 2000 for $69.46 million.	Health Technology
AGC Biologics A/S AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.	Health Technology
Recepticon ApS Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects.	Health Technology
Biotech Biotech BiotechnologyHealth Technology The private company manufactures biotechnical products. The company is based in Cambridge, MA.	Health Technology
Life Cycle Pharma A/S
Galecto Biotech ApS Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.	Health Technology

See company connections